首页> 外文期刊>中华医学杂志(英文版) >Effect of elevated total cholesterol level and hypertension on the risk of fatal cardiovascular disease: a cohort study of Chinese steelworkers
【24h】

Effect of elevated total cholesterol level and hypertension on the risk of fatal cardiovascular disease: a cohort study of Chinese steelworkers

机译:总胆固醇水平升高和高血压对致命性心血管疾病风险的影响:中国钢铁工人的队列研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background Increased blood pressure and elevated total cholesterol (TC) level are the two most important modifiable risk factors of cardiovascular disease (CVD) in the world.Hypertension and hypercholesterolemia co-exist more often than would be expected and whether there is a synergistic impact on fatal CVD between elevated TC and hypertension need to be further examined in Chinese population.Methods We conducted a cohort study which recruited 5092 Chinese male steelworkers aged 18-74 years in 1974-1980 and followed up for an average of 20.84 years.Totally 302 fatal CVD events were documented by the year of 2001.Cox proportional hazards regression models were undertaken to adjust for baseline variables with fatal CVD events as the outcome variable.Additive interaction model was used to evaluate the interaction between elevated TC and hypertension.Results Hypercholesterolemia and hypertension were significantly associated with an increased hazard ratio (HR) of fatal CVD (1.67 (95% CI 1.18-2.38) and 2.91 (95% CI 2.23-3.80) respectively.Compared to participants with normotension and TC <240 mg/dl,the HRs were 1.11 (95% CI 0.56-2.21),2.74 (95% CI 2.07-3.64) for hypercholesterolemia and hypertension respectively,and 5.51 (95% CI 3.58-8.46) for participants with both risk factors.There was an additive interaction with a 2.65 (95% CI 0.45-4.85) relative excess risk (RERI) between hypercholesterolemia and hypertension on CVD.Conclusion We found that the risk of fatal CVD was significantly associated with an additive interaction due to hypercholesterolemia and hypertension besides a conventional main effect derived from either of them,which highlights that the prevention and treatment of both risk factors might improve the individual risk profile thus reduce the CVD mortality.
机译:背景血压升高和总胆固醇(TC)升高是世界上心血管疾病(CVD)的两个最重要的可改变的危险因素。高血压和高胆固醇血症并存的频率比预期的要高,并且对高血压是否产生协同作用方法我们进行了一项队列研究,在1974-1980年期间招募了5092名年龄在18-74岁之间的中国男性钢铁工人,平均随访20.84年,其中302人死亡。到2001年记录了CVD事件,采用了Cox比例风险回归模型来调整以致命CVD事件为结果变量的基线变量,使用了加性相互作用模型来评估TC和高血压之间的相互作用。结果高胆固醇血症和高血压与致命性CVD的危险比(HR)升高显着相关(1.67(95%CI 1 .18-2.38)和2.91(95%CI 2.23-3.80)。与血压正常和TC <240 mg / dl的参与者相比,HRs为1.11(95%CI 0.56-2.21),2.74(95%CI 2.07-高胆固醇血症和高血压分别为3.64)和两种危险因素的参与者均为5.51(95%CI 3.58-8.46)。高胆固醇血症与高血压之间的相对过度风险(RERI)为2.65(95%CI 0.45-4.85)。结论:我们发现致命性心血管疾病的风险与高胆固醇血症和高血压所致的加性相互作用显着相关,此外,二者均具有传统的主要作用,这突出表明,预防和治疗这两种风险因素可能会改善心血管疾病的危险性。因此,个人风险状况可降低CVD死亡率。

著录项

  • 来源
    《中华医学杂志(英文版)》 |2011年第22期|3702-3706|共5页
  • 作者单位

    Department of Evidence Based Medicine, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China;

    Department of Evidence Based Medicine, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China;

    Department of Evidence Based Medicine, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China;

    Department of Evidence Based Medicine, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China;

    Department of Evidence Based Medicine, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China;

    Department of Evidence Based Medicine, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China;

    Department of Evidence Based Medicine, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China;

    Department of Evidence Based Medicine, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China;

    Department of Evidence Based Medicine, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China;

    Department of Evidence Based Medicine, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China;

  • 收录信息 中国科学引文数据库(CSCD);中国科技论文与引文数据库(CSTPCD);
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号